Is Vigabatrin included in medical insurance?

Vigabatrin (Vigabatrin) is a drug used to treat epilepsy in children aged 1 month to 7 years old. It can be used alone to treat infantile spasms (West syndrome), a rare form of epilepsy that begins at a young age, usually in the first few months of life; or with other medicines to treat partial epilepsy (seizures that affect one part of the brain), including when seizures spread to other parts of the brain and become more common. Vigabatrin is only used in partial epilepsy when the patient has tried all other suitable treatments or is unable to use them due to side effects.

Vigabatrin contains the active substancevigabatrin, a "mixed drug" available in different forms and strengths, blocks the action of an enzyme called GABA transaminase, which breaks down a substance called GABA (gamma-aminobutyric acid) in the brain. GABA reduces the brain's electrical activity. Blocking the enzyme that breaks it down increases the amount of GABA in the brain, thus increasing its effects. This helps suppress the abnormal electrical activity that causes infantile spasms and some epilepsy, thereby controlling the symptoms of these conditions.

The original Vigabatrin drug has not yet been launched in China, so it is not included in medical insurance. The Hong Kong version of the specificationsThe price of 500mg*100 bags per box may be more than 1,000 yuan (the price may fluctuate due to exchange rate effects). It is reported that an Indian chemical generic drug vigabatrin powder is on the domestic market. The price of each box of 500mg*50 bags may be more than 3,000 yuan. Its pharmaceutical ingredients are basically the same as those of the original drug. The Turkish version of Vigabatrin currently sold overseas may cost more than RMB 1,000 per box of 500mg*100 bags (the price may fluctuate due to exchange rates).